Health Canada drug identification number

DIN 02414686 — PREMARIN 0.625 MG

PREMARIN is a tablet (extended-release) of Conjugated Estrogens marketed by PFIZER CANADA ULC. The full Conjugated Estrogens monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02414686
Brand name
PREMARIN
Active ingredient
Conjugated Estrogens
Strength
0.625 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Estrogenic hormone (menopausal hormone therapy)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Conjugated Estrogens products

DINBrandStrengthFormManufacturerStatus
00265470 C.E.S. 0.625 MG TABLET BAUSCH HEALTH, CANADA INC. DORMANT
00830240 CONGEST 0.3 MG TABLET LABORATOIRE RIVA INC. DORMANT
00830232 CONGEST 0.625 MG TABLET LABORATOIRE RIVA INC. DORMANT
00830224 CONGEST 0.9 MG TABLET LABORATOIRE RIVA INC. DORMANT
00830216 CONGEST 1.25 MG TABLET LABORATOIRE RIVA INC. DORMANT
00830208 CONGEST 2.5 MG TABLET LABORATOIRE RIVA INC. DORMANT
02414678 PREMARIN 0.3 MG TABLET (EXTENDED-RELEASE) PFIZER CANADA ULC MARKETED
02414694 PREMARIN 1.25 MG TABLET (EXTENDED-RELEASE) PFIZER CANADA ULC MARKETED
02043386 PREMARIN INTRAVENOUS 25 MG POWDER FOR SOLUTION PFIZER CANADA ULC MARKETED
02043440 PREMARIN VAGINAL CREAM 0.625 MG CREAM PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.